Fosun Pharma shareholder reduces pledged shares to 23%

Fosun High-Tech, the controlling shareholder of Shanghai Fosun Pharmaceutical Group, reduced its pledged shares to 612,675,000 A-shares, representing 22.94% of the company's total shares.

Separately, Shanghai Fosun Pharmaceutical Group's stake in the Shanghai Jingxu Rongxu Investment Fund increased from 30.00% to 33.24% after the fund's total subscribed capital decreased from RMB 1.8 billion to RMB 1.61 billion, while Fosun Pharma maintained its RMB 600 million commitment.